120 related articles for article (PubMed ID: 9987775)
41. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters.
Holzapfel HP; Führer D; Wonerow P; Weinland G; Scherbaum WA; Paschke R
J Clin Endocrinol Metab; 1997 Dec; 82(12):4229-33. PubMed ID: 9398745
[TBL] [Abstract][Full Text] [Related]
42. Iodine-123 SPECT of the thyroid in multinodular goiter.
Chen JJ; LaFrance ND; Rippin R; Allo MD; Wagner HN
J Nucl Med; 1988 Jan; 29(1):110-3. PubMed ID: 3257257
[TBL] [Abstract][Full Text] [Related]
43. Separation of autonomous function from cell density in non-immunogenic hyperthyroidism--II. quantified comparison before and after radioiodine therapy.
Als C; Rösler H; Listewnik M
Nuklearmedizin; 1996 Feb; 35(1):12-9. PubMed ID: 8746167
[TBL] [Abstract][Full Text] [Related]
44. Effects of recombinant human thyroid-stimulating hormone superagonists on thyroidal uptake of 18F-fluorodeoxyglucose and radioiodide.
Reinfelder J; Maschauer S; Foss CA; Nimmagadda S; Fremont V; Wolf V; Weintraub BD; Pomper MG; Szkudlinski MW; Kuwert T; Prante O
Thyroid; 2011 Jul; 21(7):783-92. PubMed ID: 21568725
[TBL] [Abstract][Full Text] [Related]
45. Screening of thyrotropin receptor mutations by fine-needle aspiration biopsy in autonomous functioning thyroid nodules in multinodular goiters.
Tassi V; Di Cerbo A; Porcellini A; Papini E; Cisternino C; Crescenzi A; Scillitani A; Pizzuti A; Ratti A; Trischitta V; Avvedimento VE; Fenzi G; De Filippis V
Thyroid; 1999 Apr; 9(4):353-7. PubMed ID: 10319940
[TBL] [Abstract][Full Text] [Related]
46. [Studies on the function of the autonomous adenoma of the thyroid gland (author's transl)].
Breuel HP; Weidel C; Fischer P; Bähre M; Altland H; Biersack HJ
Nuklearmedizin; 1979 Oct; 18(4):193-9. PubMed ID: 119209
[TBL] [Abstract][Full Text] [Related]
47. [Quantitated thyroid scan (123I) of the thyroid nodule: a new molecular imaging].
Clerc J
J Radiol; 2009 Mar; 90(3 Pt 2):371-91. PubMed ID: 19421128
[TBL] [Abstract][Full Text] [Related]
48. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
Paschke R
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
[TBL] [Abstract][Full Text] [Related]
49. Delayed radioiodine organification in Plummer's disease.
Intenzo CM; Park CH; Kim SM
Clin Nucl Med; 1995 Mar; 20(3):203-5. PubMed ID: 7750210
[TBL] [Abstract][Full Text] [Related]
50. Induction of TSH-receptor antibodies in patients with toxic multinodular goitre by radioiodine treatment.
Wallaschofski H; Müller D; Georgi P; Paschke R
Horm Metab Res; 2002 Jan; 34(1):36-9. PubMed ID: 11833000
[TBL] [Abstract][Full Text] [Related]
51. A comparison of plasma TSH levels in patients with diffuse and nodular non-toxic goiter.
Toft AD; Irvine WJ; Hunter WM
J Clin Endocrinol Metab; 1976 May; 42(5):973-6. PubMed ID: 1270586
[TBL] [Abstract][Full Text] [Related]
52. Follow-up of solitary autonomous thyroid nodules treated with 131I.
Goldstein R; Hart IR
N Engl J Med; 1983 Dec; 309(24):1473-6. PubMed ID: 6646172
[TBL] [Abstract][Full Text] [Related]
53. The FDG Pattern of Autonomously Functioning Thyroid Nodules Correlates With Thyroid-Stimulating Hormone and Histopathology.
Piccardo A; Fiz F; Bottoni G; Massollo M; Puntoni M; Catrambone U; Foppiani L; Bertagna F; Albano D; Trimboli P
Clin Nucl Med; 2023 Feb; 48(2):119-125. PubMed ID: 36260757
[TBL] [Abstract][Full Text] [Related]
54. [Treatment results in radio-iodine therapy of the autonomous adenoma of the thyroid gland (author's transl)].
Meydam K; Lichtenberg T
Rontgenblatter; 1981 Feb; 34(2):66-9. PubMed ID: 7209303
[TBL] [Abstract][Full Text] [Related]
55. [How does it function? Radioiodine therapy].
Schicha H
MMW Fortschr Med; 2003 Oct; 145(42):71-2. PubMed ID: 14655457
[No Abstract] [Full Text] [Related]
56. FDG PET in thyroid cancer: thyroxine or not?
Grünwald F; Biersack HJ
J Nucl Med; 2000 Dec; 41(12):1996-8. PubMed ID: 11138684
[No Abstract] [Full Text] [Related]
57. Intense FDG uptake in a benign Hurthle cell adenoma.
Rohren EM
Clin Nucl Med; 2004 Oct; 29(10):664-6. PubMed ID: 15365450
[No Abstract] [Full Text] [Related]
58. [Autonomous thyroid adenoma. Value of thallium scintigraphy and pathology].
Van Espen MB; Hermans J; Bodart F; Schmitz A; François D; Beauduin M
Ann Endocrinol (Paris); 1997; 58(6):482-93. PubMed ID: 9686008
[TBL] [Abstract][Full Text] [Related]
59. Huge thyroid uptake of 18F-FDG in a patient with Hashimoto's thyroiditis referred for a malignant thyroid lesion.
Yoshihara A; Isozaki O; Okubo Y; Maki M; Kusakabe K; Takano K
Thyroid; 2008 May; 18(5):579-80. PubMed ID: 18407754
[No Abstract] [Full Text] [Related]
60. Second thoughts on the value of selective thyroid angiography.
Damascelli B; Cascinelli N; Terno G; Dragoni G; Saccozzi R
Am J Roentgenol Radium Ther Nucl Med; 1972 Apr; 114(4):822-9. PubMed ID: 5026247
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
